Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
no refrigeration needed Retatrutide (triple-agonist GLP-1, GIP, glucagon) Status: Currently in Phase II/III trials Average weight loss: 17.524% in initial studies Notable facts: Promising triple-targeting mechanism for substantial weight reduction Mazdutide (IBI-362) Status: Approved in China as of June 2025
Before you receive your aligners, 3D images of your teeth are taken, and the orthodontist orders sets of custom-fit aligners are force your teeth into position gradually
Otherwise, the medication is a flat $90 cash price
N Engl J Med (2016) 375:32334
US$ 29.58
US$ 24.44
US$ 21.48
US$ 22.94
US$ 21.57
US$ 29.04
